Biotech Clinical Analytics Solution Assessment and Roadmap

A rapidly expanding commercial biotech was conducting numerous clinical trials across therapeutic areas at various global sites. With a goal of better supporting the business’ changing and growing clinical operational analytical needs, the client engaged Triverus for an independent Assessment and Roadmap.  Due to expansion and use of multiple disparate applications and reporting challenges, the business reached an inflexion point to answer a key question:

“Should we continue to expand our existing reporting and analytics environment, seek other solutions or develop a custom solution?”

Specifically, the client sought to understand what opportunities exist to improve the efficiency and effectiveness of its operations as well as its ability to address both current and future business needs and direction.  

How We Helped

Triverus’ Life Sciences team met with business leadership across clinical areas, including Portfolio Management and Clinical Operations, to determine the needs of the organization and define an actionable roadmap. Activities included:

Utilizing a proven assessment methodology to evaluate the current environment and its capabilities via:

• Structured workshops leveraging Triverus frameworks by subject area
• Periodic feedback sessions to review findings and interim recommendations to ensure alignment and resolve inconsistencies.

Analyzing current state and applying industry experience to identify:

• Inconsistent business practices and processes
• Significant areas for improvement.

Compiling results and findings into a structured format with:

• A gaps and risks summary
• Prioritized recommendations
• A time-based roadmap of actionable initiatives.

Results

To help the client answer their critical questions, the team successfully addressed process, technology and organization issues by providing a set of critical recommendations, including:

• Standardizing the clinical trial planning process, including cadence, frequency and nomenclature.
• Consolidating plans and sub-plans for all clinical functional areas into a single solution.
• Reducing potential business disruption by retaining the existing reporting platform while extending its capabilities.
• Eliminating duplication of HCPs and HCO’s with Master Data Management processes.

And the client can confidently move to a more robust future state with a new prioritized actionable roadmap of initiatives that is aligned with budget, resources and time constraints. Highlighted benefits include:

• Preserving the baseline solution.
• Incorporating a series of releases to achieve business value in phases.
• Providing a unified direction for the business and IT to embrace.